Kuehn Law Encourages Investors of Exicure, Inc. to Contact Law Firm
New York, New York--(Newsfile Corp. - January 27, 2025) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Exicure, Inc. (NASDAQ: XCUR) breached their fiduciary duties to shareholders. According to a federal securities lawsuit, Exicure insiders caused the company to misrepresent or fail to disclose that (1) that there had been certain improprieties in Exicure's preclinical program for the treatment of Friedreich's ataxia; (2) that, as a result, there was...
2025-01-27 10:01 AM EST
Kuehn Law Encourages Investors of Crocs, Inc. to Contact Law Firm
New York, New York--(Newsfile Corp. - January 27, 2025) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Crocs, Inc. (NASDAQ: CROX) breached their fiduciary duties to shareholders. According to a federal securities lawsuit, Crocs insiders caused the company to misrepresent or fail to disclose that (1) the nature and sustainability of HEYDUDE's revenue growth by concealing that 2022 revenue growth was driven, in large part, by the Company's efforts...
2025-01-27 9:58 AM EST
Kuehn Law Encourages Investors of Block, Inc. to Contact Law Firm
New York, New York--(Newsfile Corp. - January 27, 2025) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Block, Inc. (NYSE: XYZ) breached their fiduciary duties to shareholders. According to a federal securities lawsuit, Block insiders caused the company to misrepresent or fail to disclose that (i) Block had engaged in widespread and years-long compliance lapses at Square and Cash App, including by failing to conduct basic due diligence regarding...
2025-01-27 9:52 AM EST
Kuehn Law Encourages Investors of ProKidney Corp. to Contact Law Firm
New York, New York--(Newsfile Corp. - January 7, 2025) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of ProKidney Corp. (NASDAQ: PROK) breached their fiduciary duties to shareholders. The investigation concerns potential self-dealing. Shareholders may be entitled to damages and corporate governance reforms.If you are a long-term PROK stockholder please contact Justin Kuehn, Esq. here, by email at justin@kuehn.law, or call (833) 672-0814. The consultation and case are free...
2025-01-07 5:48 PM EST
Kuehn Law Encourages Investors of OmniAb, Inc. to Contact Law Firm
New York, New York--(Newsfile Corp. - January 7, 2025) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of OmniAb, Inc. (NASDAQ: OABI) breached their fiduciary duties to shareholders. The investigation concerns potential self-dealing. Shareholders may be entitled to damages and corporate governance reforms.If you are a long-term OABI stockholder please contact Justin Kuehn, Esq. here, by email at justin@kuehn.law, or call (833) 672-0814. The consultation and case are free...
2025-01-07 5:46 PM EST
Kuehn Law Encourages Investors of Verve Therapeutics, Inc. to Contact Law Firm
New York, New York--(Newsfile Corp. - January 7, 2025) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Verve Therapeutics, Inc. (NASDAQ: VERV) breached their fiduciary duties to shareholders. The investigation concerns potential self-dealing. Shareholders may be entitled to damages and corporate governance reforms.If you are a long-term VERV stockholder please contact Justin Kuehn, Esq. here, by email at justin@kuehn.law, or call (833) 672-0814. The consultation and case are...
2025-01-07 5:37 PM EST
Kuehn Law Encourages Investors of ON24, Inc. to Contact Law Firm
New York, New York--(Newsfile Corp. - January 7, 2025) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of ON24, Inc. (NYSE: ONTF) breached their fiduciary duties to shareholders. The investigation concerns potential self-dealing. Shareholders may be entitled to damages and corporate governance reforms.If you are a long-term ONTF stockholder please contact Justin Kuehn, Esq. here, by email at justin@kuehn.law, or call (833) 672-0814. The consultation and case are free...
2025-01-07 5:34 PM EST
Kuehn Law Encourages Investors of Methode Electronics, Inc. to Contact Law Firm
New York, New York--(Newsfile Corp. - January 6, 2025) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Methode Electronics, Inc. (NYSE: MEI) breached their fiduciary duties to shareholders.According to a federal securities lawsuit, Methode insiders caused the company to misrepresent or fail to disclose that (i) Methode Electronics lost skilled employees during the COVID-19 pandemic, hindering their transition to a high mix, low volume production model at Monterrey; (ii) Efforts...
2025-01-06 10:04 PM EST
Kuehn Law Encourages Investors of Orthofix Medical Inc. to Contact Law Firm
New York, New York--(Newsfile Corp. - January 6, 2025) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Orthofix Medical Inc. (NASDAQ: OFIX) breached their fiduciary duties to shareholders.A federal securities lawsuit alleges that Orthofix Medical insiders caused the company to misrepresent or fail to disclose material information regarding the conduct of the management team. The lawsuit claims that Orthofix's management team engaged in conduct that violated multiple code of conduct...
2025-01-06 5:54 PM EST
Kuehn Law Encourages Investors of Prime Medicine, Inc. to Contact Law Firm
New York, New York--(Newsfile Corp. - January 3, 2025) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Prime Medicine, Inc. (NASDAQ: PRME) breached their fiduciary duties to shareholders. The investigation concerns potential self-dealing. Shareholders may be entitled to damages and corporate governance reforms.If you are a long-term PRME stockholder please contact Justin Kuehn, Esq. here, by email at justin@kuehn.law, or call (833) 672-0814. The consultation and case are free...
2025-01-03 1:22 PM EST
Kuehn Law Encourages Investors of Cytokinetics, Inc. to Contact Law Firm
New York, New York--(Newsfile Corp. - January 3, 2025) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Cytokinetics, Inc. (NASDAQ: CYTK) breached their fiduciary duties to shareholders. The investigation concerns potential self-dealing. Shareholders may be entitled to damages and corporate governance reforms.If you are a long-term CYTK stockholder please contact Justin Kuehn, Esq. here, by email at justin@kuehn.law, or call (833) 672-0814. The consultation and case are free...
2025-01-03 12:45 PM EST
Kuehn Law Encourages Investors of Starbucks Corp to Contact Law Firm
New York, New York--(Newsfile Corp. - December 31, 2024) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Starbucks Corp (NASDAQ: SBUX) breached their fiduciary duties to shareholders.According to a federal securities lawsuit, Starbucks insiders caused the company to misrepresent or fail to disclose material information concerning Starbucks' fiscal year revenue for 2023 and expected guidance for the fiscal year 2024. On April 30, 2024, the company announced disappointing Q2 Fiscal...
2024-12-31 4:16 PM EST
Kuehn Law Encourages Investors of DexCom, Inc. to Contact Law Firm
New York, New York--(Newsfile Corp. - December 31, 2024) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of DexCom, Inc. (NASDAQ: DXCM) breached their fiduciary duties to shareholders.According to a federal securities lawsuit, DexCom insiders caused the company to misrepresent or fail to disclose material information concerning expected revenue for the fiscal year 2024. On July 25, 2024, Dexcom announced its financial results for the second quarter of fiscal 2024...
2024-12-31 4:13 PM EST
Kuehn Law Encourages Investors of Mobileye Global Inc. to Contact Law Firm
New York, New York--(Newsfile Corp. - December 31, 2024) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Mobileye Global Inc. (NASDAQ: MBLY) breached their fiduciary duties to shareholders.According to a federal securities lawsuit, Mobileye Global insiders caused the company to misrepresent or fail to disclose that (1) to avoid the shortages experienced amid supply chain constraints in 2021 and 2022, the company's Tier 1 customers had purchased inventory in excess of...
2024-12-31 4:09 PM EST
Kuehn Law Encourages Investors of Gitlab Inc. to Contact Law Firm
New York, New York--(Newsfile Corp. - December 31, 2024) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Gitlab Inc. (NASDAQ: GTLB) breached their fiduciary duties to shareholders.According to a federal securities lawsuit, Gitlab insiders caused the company to misrepresent or fail to disclose material adverse facts concerning GitLab's ability to develop AI features that would generate code more efficiently and increase market demand for its DevSecOps platform, and, as a result,...
2024-12-31 1:06 PM EST
Kuehn Law Encourages Investors of Outset Medical, Inc. to Contact Law Firm
New York, New York--(Newsfile Corp. - December 31, 2024) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Outset Medical, Inc. (NASDAQ: OM) breached their fiduciary duties to shareholders. According to a federal securities lawsuit, Outset insiders caused the company to misrepresent or fail to disclose that (1) the Tablo products were marketed for continuous renal replacement therapy, which is not one of the indications approved by the FDA; (2) that,...
2024-12-31 12:54 PM EST
Kuehn Law Encourages Investors of Sage Therapeutics, Inc. to Contact Law Firm
New York, New York--(Newsfile Corp. - December 31, 2024) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Sage Therapeutics, Inc. (NASDAQ: SAGE) breached their fiduciary duties to shareholders. According to a federal securities lawsuit, Sage insiders caused the company to misrepresent or fail to disclose that (i) zuranolone was less effective in treating MDD than the company had led investors to believe; (ii) accordingly, the FDA was unlikely to approve...
2024-12-31 12:50 PM EST
Kuehn Law Encourages Investors of Akero Therapeutics, Inc. to Contact Law Firm
New York, New York--(Newsfile Corp. - December 30, 2024) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Akero Therapeutics, Inc. (NASDAQ: AKRO) breached their fiduciary duties to shareholders. The investigation concerns potential self-dealing. Shareholders may be entitled to damages and corporate governance reforms.If you are a long-term AKRO stockholder please contact Justin Kuehn, Esq. here, by email at justin@kuehn.law, or call (833) 672-0814. The consultation and case are...
2024-12-30 5:30 PM EST
Kuehn Law Encourages Investors of Corcept Therapeutics Inc. to Contact Law Firm
New York, New York--(Newsfile Corp. - December 30, 2024) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Corcept Therapeutics Inc. (NASDAQ: CORT) breached their fiduciary duties to shareholders. The investigation concerns potential self-dealing. Shareholders may be entitled to damages and corporate governance reforms.If you are a long-term CORT stockholder please contact Justin Kuehn, Esq. here, by email at justin@kuehn.law, or call (833) 672-0814. The consultation and case are...
2024-12-30 5:26 PM EST
Kuehn Law Encourages Investors of Immunovant, Inc. to Contact Law Firm
New York, New York--(Newsfile Corp. - December 30, 2024) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Immunovant, Inc. (NASDAQ: IMVT) breached their fiduciary duties to shareholders. The investigation concerns potential self-dealing. Shareholders may be entitled to damages and corporate governance reforms.If you are a long-term IMVT stockholder please contact Justin Kuehn, Esq. here, by email at justin@kuehn.law, or call (833) 672-0814. The consultation and case are free...
2024-12-30 5:23 PM EST